The Discounted Cash Flow (DCF) valuation of Finch Therapeutics Group Inc (FNCH) is (1,444.67) USD. With the latest stock price at 7.45 USD, the upside of Finch Therapeutics Group Inc based on DCF is -19491.6%.
Based on the latest price of 7.45 USD and our DCF valuation, Finch Therapeutics Group Inc (FNCH) is a sell. selling FNCH stocks now will result in a potential gain of 19491.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.1% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3,059.42) - (966.00) | (1,444.67) |
| Upside | -41166.1% - -13066.5% | -19491.6% |